Bank Julius Baer & Co
TMO icon

Bank Julius Baer & Co’s Thermo Fisher Scientific TMO Stock Holding History

Bank Julius Baer & Co’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.5M Sell
22,999
-29,803
-56% -$14.3M 0.03% 197
2026
Q1 		$26M Sell
52,802
-2,162
-4% -$1.17M 0.08% 132
2025
Q4 		$31.8M Sell
54,964
-6,880
-11% -$3.89M 0.09% 128
2025
Q3 		$30M Sell
61,844
-314,724
-84% -$146M 0.08% 126
2025
Q2 		$153M Sell
376,568
-103,825
-22% -$43.4M 0.45% 62
2025
Q1 		$239M Buy
480,393
+37,565
+8% +$20.3M 0.78% 39
2024
Q4 		$248M Buy
442,828
+3,015
+0.7% +$1.66M 0.77% 31
2024
Q3 		$311M Sell
439,813
-21,298
-5% -$12.6M 1.05% 26
2024
Q2 		$278M Sell
461,111
-35,113
-7% -$20.1M 1.06% 25
2024
Q1 		$287M Buy
496,224
+69,229
+16% +$38.8M 1.1% 22
2023
Q4 		$264M Sell
426,995
-4,820
-1% -$2.33M 1.12% 21
2023
Q3 		$219M Buy
431,815
+22,269
+5% +$11.9M 1.27% 22
2023
Q2 		$214M Buy
409,546
+6,628
+2% +$3.58M 1.27% 24
2023
Q1 		$232M Sell
402,918
-9,861
-2% -$5.56M 1.48% 17
2022
Q4 		$227M Sell
412,779
-64,334
-13% -$34.1M 1.55% 18
2022
Q3 		$242M Sell
477,113
-72,699
-13% -$40.7M 1.84% 14
2022
Q2 		$299M Sell
549,812
-164,465
-23% -$90.5M 2.11% 10
2022
Q1 		$422M Buy
714,277
+30,793
+5% +$17.7M 2.53% 8
2021
Q4 		$456M Buy
683,484
+32,762
+5% +$20.5M 2.44% 8
2021
Q3 		$372M Buy
650,722
+40,866
+7% +$22.4M 2.31% 9
2021
Q2 		$308M Buy
609,856
+18,413
+3% +$8.69M 1.95% 11
2021
Q1 		$270M Sell
591,443
-50,478
-8% -$24.1M 2.02% 10
2020
Q4 		$299M Buy
641,921
+530,026
+474% +$249M 2.45% 10
2020
Q3 		$49.4M Buy
111,895
+108,195
+2,924% +$44.7M 0.48% 51
2020
Q2 		$40.7M Sell
3,700
-106,660
-97% -$35.8M 0.47% 52
2020
Q1 		$31.3M Buy
+110,360
New +$34.8M 0.72% 40

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Bank Julius Baer & Co's TMO Position: Q2 2026 in Review

Bank Julius Baer & Co reduced its Thermo Fisher Scientific (TMO) stake by 56% in Q2 2026, selling an estimated $14.3M and leaving 22,999 shares worth $11.5M. The position accounts for 0.03% of the portfolio, ranked #197.

Bank Julius Baer & Co first reported a position in TMO in Q1 2020 and has held it in 26 quarters since. The position peaked at $456M in Q4 2021. 2,620 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Bank Julius Baer & Co held 22,999 shares of Thermo Fisher Scientific worth $11.5M as of Q2 2026.
  • Bank Julius Baer & Co sold 29,803 Thermo Fisher Scientific shares in Q2 2026, an estimated $14.3M.
  • Thermo Fisher Scientific made up 0.03% of Bank Julius Baer & Co's portfolio in Q2 2026, its #197 holding.
  • Bank Julius Baer & Co first reported a position in Thermo Fisher Scientific in Q1 2020 and has held it in 26 quarters since.
  • Bank Julius Baer & Co's Thermo Fisher Scientific position peaked at $456M in Q4 2021.
  • 2,620 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Bank Julius Baer & Co's 13F filing for Q2 2026, filed 10 Aug 2026.